NR4A1 inhibition synergizes with ibrutinib in killing mantle cell lymphoma cells

Blood Cancer J. 2017 Nov 23;7(12):632. doi: 10.1038/s41408-017-0005-z.

Yangguang Li^{1

2}, Fangyu Wang^{1

2}, Li Lu^{1

2}, Fen Zhu^{1

2}, Shengjian Huang³, Krystle Nomie³, Liang Zhang³, David T Yang^{2

4}, Wei Huang⁴, Brad S Kahl⁵, Stephen Safe⁶, Michael Wang³, Lixin Rui^{7

8}

¹ Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53792, USA.
² Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53792, USA.
³ Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
⁴ Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53792, USA.
⁵ Department of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
⁶ Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, 77843, USA.
⁷ Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53792, USA. lrui@medicine.wisc.edu.
⁸ Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53792, USA. lrui@medicine.wisc.edu.

No abstract available

Publication types